JAMDA
February 27, 2022
Showing 81 - 90 of 2742 results
JAMDA
October 7, 2021
Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes
This study evaluated logistics, process data, and barriers/facilitators for the implementation and use of C-reactive protein point-of-care testing (CRP POCT) for suspected lower respiratory tract infections (LRTIs) in nursing home (NH) residents.
JAMDA
July 21, 2021
Nursing Home Antibiotic Stewardship Policy and Antibiotics Use: 2013–2017
Reducing inappropriate nursing home (NH) antibiotic usage by implementing stewardship programs is a national priority. Our aim is to evaluate the influence of antibiotic stewardship programs on antibiotic use rates in NHs over time.
JAMDA
January 16, 2025
Long-Stay Nursing Home Residents with Dementia: Telemedicine Mental Health Use during the COVID-19 Pandemic
To examine racial and ethnic differences in telemedicine mental health (tele-MH) use among nursing home (NH) long-stay residents with Alzheimer’s disease and related dementias (ADRD) during the pandemic.
JAMDA
January 25, 2019
Standards for the Use of Telemedicine for Evaluation and Management of Resident Change of Condition in the Nursing Home
This document offers guidance to clinicians and facilities on the use of telemedicine to deliver medically necessary evaluation and management of change of condition for nursing home residents.
JAMDA
May 25, 2023
Trends in COVID-19–Related Medication Use in US Nursing Homes, 2018-2022
Little is known about how COVID-19 treatment patterns have evolved over time in nursing homes (NHs) despite the devastating effects of COVID-19 in this setting. The aim was to describe changes in COVID-19–related medication use over time among NH residents in the United States.
JAMDA
July 31, 2015
The Effect of Depressive Symptoms and Antidepressant Use on Subsequent Physical Decline and Number of Hospitalizations in Nursing Home Residents: A 9-Year Longitudinal Study
To investigate whether depressive symptoms and antidepressant use at baseline predict the subsequent decline in physical functioning and number of hospitalizations in nursing home residents.
JAMDA
August 5, 2023
Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZD...
JAMDA
January 30, 2024
Sliding Scale Insulin Use in Nursing Homes Before and After Onset of the COVID-19 Pandemic
To characterize sliding-scale insulin (SSI) use in US nursing homes (NHs) before and after the COVID-19 pandemic.
JAMDA
May 24, 2020
The Negative Impact of Psychotropic Drug Use on Quality of Life in Nursing Home Patients at Different Stages of Dementia: Cross-Sectional Analyses from the COSMOS Trial
The quality of life (QoL) in nursing home (NH) patients with dementia is threatened by neuropsychiatric symptoms. This may trigger the use of psychotropic drugs, yet it is unknown if this practice improves the QoL. We investigated the association between the number of psychotropic drugs and QoL at differen...
